Gene: Ttk (Ttk protein kinase) Rattus norvegicus
Analyze
Symbol:
Ttk
Name:
Ttk protein kinase
RGD ID:
1305558
Description:
Predicted to have identical protein binding activity; kinetochore binding activity; and protein kinase activity. Predicted to be involved in several processes, including negative regulation of metaphase/anaphase transition of cell cycle; protein localization to organelle; and protein phosphorylation. Predicted to localize to several cellular components, including kinetochore; nucleus; and spindle. Orthologous to human TTK (TTK protein kinase); PARTICIPATES IN cell cycle pathway, mitotic; INTERACTS WITH 1-naphthyl isothiocyanate; 2,3,7,8-tetrachlorodibenzodioxine; 6-propyl-2-thiouracil.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Also known as:
dual specificity protein kinase TTK; LOC315852; Monopolar spindle 1; Mps1
Orthologs:
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
TTK (TTK protein kinase) HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, Panther
Mus musculus (house mouse):
Ttk (Ttk protein kinase) HGNC
EggNOG, NCBI, OMA, HomoloGene, Inparanoid, Panther, OrthoDB, Ensembl
Chinchilla lanigera (long-tailed chinchilla):
Ttk (TTK protein kinase) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
TTK (TTK protein kinase) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
TTK (TTK protein kinase) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Ttk (TTK protein kinase) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
TTK (TTK protein kinase) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (African green monkey):
TTK (TTK protein kinase) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Ttk (TTK protein kinase) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Homo sapiens (human):
TTK (TTK protein kinase)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER)
Mus musculus (house mouse):
Ttk (Ttk protein kinase)
Alliance
DIOPT (Hieranoid|InParanoid|OrthoFinder|OrthoInspector|PANTHER)
Danio rerio (zebrafish):
ttk (ttk protein kinase)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER)
Saccharomyces cerevisiae (baker's yeast):
MPS1
Alliance
DIOPT (Ensembl Compara|Hieranoid|OrthoInspector|PANTHER)
Drosophila melanogaster (fruit fly):
Mps1
Alliance
DIOPT (Ensembl Compara|OrthoFinder|OrthoInspector|PANTHER)
Latest Assembly:
Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Rnor_6.0 8 91,368,065 - 91,405,995 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 8 91,368,111 - 91,405,993 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 8 90,886,724 - 90,924,327 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 8 88,906,665 - 88,944,613 (+) NCBI RGSC3.4 rn4 RGSC3.4 Celera 8 84,402,963 - 84,441,218 (+) NCBI Celera Cytogenetic Map 8 q31 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Imported Annotations - ClinVar
Pancreatic Neoplasms ISO RGD:1313655 8554872 ClinVar Annotator: match by term: Pancreatic Neoplasms ClinVar PMID:20581473
Imported Annotations - CTD
hepatocellular carcinoma ISO RGD:1313655 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:28284560 polycystic ovary syndrome ISO RGD:1313655 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:21411543
(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1313655 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TTK mRNA CTD PMID:22079256 1,1-dichloroethene increases expression ISO RGD:1313656 6480464 vinylidene chloride results in increased expression of TTK mRNA CTD PMID:26682919 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of TTK mRNA CTD PMID:30723492 17beta-estradiol increases expression ISO RGD:1313655 6480464 Estradiol results in increased expression of TTK mRNA CTD PMID:18310284 more ... 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1313656 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1313656 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1313655 6480464 Tetrachlorodibenzodioxin affects the expression of TTK mRNA CTD PMID:22298810 , PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of TTK mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1313656 6480464 Tetrachlorodibenzodioxin affects the expression of TTK mRNA CTD PMID:26377647 2-methylcholine affects expression ISO RGD:1313655 6480464 beta-methylcholine affects the expression of TTK mRNA CTD PMID:21179406 3-methylcholanthrene increases expression ISO RGD:1313656 6480464 Methylcholanthrene results in increased expression of TTK mRNA CTD PMID:20713471 5-azacytidine multiple interactions ISO RGD:1313655 6480464 [Azacitidine co-treated with Thalidomide] affects the expression of TTK mRNA CTD PMID:18720364 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of TTK mRNA CTD PMID:24780913 7,9-dihydro-1H-purine-2,6,8(3H)-trione multiple interactions ISO RGD:1313656 6480464 NLRP3 gene mutant form inhibits the reaction [Uric Acid results in decreased expression of TTK mRNA] CTD PMID:23619996 7,9-dihydro-1H-purine-2,6,8(3H)-trione decreases expression ISO RGD:1313656 6480464 Uric Acid results in decreased expression of TTK mRNA CTD PMID:23619996 acetamide increases expression EXP 6480464 acetamide results in increased expression of TTK mRNA CTD PMID:31881176 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of TTK mRNA CTD PMID:28959563 aflatoxin B1 affects expression ISO RGD:1313655 6480464 Aflatoxin B1 affects the expression of TTK protein CTD PMID:20106945 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of TTK mRNA CTD PMID:23630614 , PMID:25378103 aflatoxin M1 decreases expression ISO RGD:1313655 6480464 Aflatoxin M1 results in decreased expression of TTK mRNA CTD PMID:30928695 azathioprine decreases expression ISO RGD:1313655 6480464 Azathioprine results in decreased expression of TTK mRNA CTD PMID:22623647 benzo[a]pyrene decreases expression ISO RGD:1313656 6480464 Benzo(a)pyrene results in decreased expression of TTK mRNA CTD PMID:19770486 benzo[a]pyrene decreases expression ISO RGD:1313655 6480464 Benzo(a)pyrene results in decreased expression of TTK mRNA CTD PMID:16120219 more ... benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1313655 6480464 7 more ... CTD PMID:20018196 , PMID:20382639 bis(2-chloroethyl) sulfide decreases expression ISO RGD:1313656 6480464 Mustard Gas results in decreased expression of TTK mRNA CTD PMID:18955075 bis(2-chloroethyl) sulfide decreases expression ISO RGD:1313655 6480464 Mustard Gas results in decreased expression of TTK mRNA CTD PMID:25102026 bis(2-chloroethyl) sulfide increases expression ISO RGD:1313656 6480464 Mustard Gas results in increased expression of TTK mRNA CTD PMID:15674844 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in decreased expression of TTK mRNA CTD PMID:26496021 bisphenol A decreases expression ISO RGD:1313655 6480464 bisphenol A results in decreased expression of TTK mRNA CTD PMID:29275510 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of TTK mRNA CTD PMID:25181051 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of TTK mRNA CTD PMID:25993096 calcitriol multiple interactions ISO RGD:1313655 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of TTK mRNA CTD PMID:21592394 calcitriol decreases expression ISO RGD:1313655 6480464 Calcitriol results in decreased expression of TTK mRNA CTD PMID:21592394 carbon nanotube decreases expression ISO RGD:1313655 6480464 Nanotubes, Carbon results in decreased expression of TTK mRNA CTD PMID:15585362 cefaloridine decreases expression EXP 6480464 Cephaloridine results in decreased expression of TTK mRNA CTD PMID:18500788 choline multiple interactions ISO RGD:1313656 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TTK gene CTD PMID:20938992 cisplatin multiple interactions ISO RGD:1313655 6480464 Cisplatin promotes the reaction [Piroxicam results in decreased expression of TTK mRNA] CTD PMID:21858171 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of TTK mRNA CTD PMID:22023808 cisplatin increases expression ISO RGD:1313656 6480464 Cisplatin results in increased expression of TTK mRNA CTD PMID:21151649 clofibrate multiple interactions ISO RGD:1313656 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of TTK mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of TTK mRNA] CTD PMID:17585979 copper(II) sulfate decreases expression ISO RGD:1313655 6480464 Copper Sulfate results in decreased expression of TTK mRNA CTD PMID:19549813 coumestrol multiple interactions ISO RGD:1313655 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 coumestrol increases expression ISO RGD:1313655 6480464 Coumestrol results in increased expression of TTK mRNA CTD PMID:19167446 cryptolepine decreases expression ISO RGD:1313655 6480464 cryptolepine results in decreased expression of TTK mRNA CTD PMID:16120219 cyclosporin A decreases expression ISO RGD:1313655 6480464 Cyclosporine results in decreased expression of TTK mRNA CTD PMID:20106945 , PMID:21632981 cylindrospermopsin decreases expression ISO RGD:1313655 6480464 cylindrospermopsin results in decreased expression of TTK mRNA CTD PMID:30905859 deoxynivalenol increases expression ISO RGD:1313655 6480464 deoxynivalenol results in increased expression of TTK mRNA CTD PMID:31863870 diazinon affects expression EXP 6480464 Diazinon affects the expression of TTK mRNA CTD PMID:22546817 dibutyl phthalate decreases expression ISO RGD:1313656 6480464 Dibutyl Phthalate results in decreased expression of TTK mRNA CTD PMID:17361019 , PMID:21266533 dichloroacetic acid increases expression ISO RGD:1313656 6480464 Dichloroacetic Acid results in increased expression of TTK mRNA CTD PMID:28962523 dicrotophos decreases expression ISO RGD:1313655 6480464 dicrotophos results in decreased expression of TTK mRNA CTD PMID:28302478 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of TTK mRNA CTD PMID:22546817 dorsomorphin multiple interactions ISO RGD:1313655 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TTK mRNA CTD PMID:27188386 doxorubicin affects response to substance ISO RGD:1313655 6480464 TTK protein affects the susceptibility to Doxorubicin CTD PMID:16217747 Enterolactone multiple interactions ISO RGD:1313655 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TTK mRNA CTD PMID:19167446 Enterolactone increases expression ISO RGD:1313655 6480464 2, 3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of TTK mRNA CTD PMID:19167446 etoposide decreases expression ISO RGD:1313655 6480464 Etoposide results in decreased expression of TTK mRNA CTD PMID:16120219 folic acid multiple interactions ISO RGD:1313656 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TTK gene CTD PMID:20938992 fulvestrant multiple interactions ISO RGD:1313655 6480464 [fulvestrant co-treated with Sirolimus] results in decreased expression of TTK mRNA CTD PMID:19016759 fulvestrant decreases expression ISO RGD:1313655 6480464 fulvestrant results in decreased expression of TTK mRNA CTD PMID:19016759 furan increases expression EXP 6480464 furan results in increased expression of TTK mRNA CTD PMID:25539665 genistein affects expression ISO RGD:1313655 6480464 Genistein affects the expression of TTK mRNA CTD PMID:18847459 geraniol decreases expression ISO RGD:1313655 6480464 geraniol results in decreased expression of TTK mRNA CTD PMID:27683099 GW 4064 increases expression ISO RGD:1313655 6480464 GW 4064 results in increased expression of TTK mRNA CTD PMID:31437187 irinotecan decreases expression ISO RGD:1313655 6480464 Irinotecan metabolite results in decreased expression of TTK mRNA, Irinotecan results in decreased expression of TTK mRNA CTD PMID:15956246 kojic acid decreases expression ISO RGD:1313655 6480464 kojic acid results in decreased expression of TTK mRNA CTD PMID:16595896 L-methionine multiple interactions ISO RGD:1313656 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TTK gene CTD PMID:20938992 leflunomide decreases expression ISO RGD:1313655 6480464 leflunomide results in decreased expression of TTK mRNA CTD PMID:28988120 lithium atom increases expression EXP 6480464 Lithium results in increased expression of TTK mRNA CTD PMID:21711903 lithium hydride increases expression EXP 6480464 Lithium results in increased expression of TTK mRNA CTD PMID:21711903 lucanthone decreases expression ISO RGD:1313655 6480464 Lucanthone results in decreased expression of TTK mRNA CTD PMID:21148553 methamphetamine multiple interactions EXP 6480464 [Methamphetamine co-treated with SCH 23390] results in decreased expression of TTK mRNA CTD PMID:19564919 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of TTK mRNA CTD PMID:19564919 methylseleninic acid decreases expression ISO RGD:1313655 6480464 methylselenic acid results in decreased expression of TTK mRNA CTD PMID:18548127 N-methyl-4-phenylpyridinium decreases expression ISO RGD:1313655 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of TTK mRNA CTD PMID:24810058 N-methyl-N-nitrosourea increases expression ISO RGD:1313656 6480464 Methylnitrosourea results in increased expression of TTK mRNA CTD PMID:25270620 N-nitrosodiethylamine increases expression ISO RGD:1313656 6480464 Diethylnitrosamine results in increased expression of TTK mRNA CTD PMID:17854601 N-nitrosodiethylamine multiple interactions ISO RGD:1313656 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of TTK mRNA, RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of TTK mRNA] CTD PMID:17854601 , PMID:24535843 N-Nitrosopyrrolidine decreases expression ISO RGD:1313655 6480464 N-Nitrosopyrrolidine results in decreased expression of TTK mRNA CTD PMID:32234424 nickel atom increases expression ISO RGD:1313655 6480464 Nickel results in increased expression of TTK mRNA CTD PMID:25583101 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of TTK mRNA CTD PMID:22546817 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of TTK mRNA CTD PMID:25729387 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of TTK mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1313656 6480464 [NOTCH3 gene mutant form affects the susceptibility to Ozone] which affects the expression of TTK mRNA CTD PMID:25658374 ozone increases expression ISO RGD:1313656 6480464 Ozone results in increased expression of TTK mRNA CTD PMID:25658374 palbociclib decreases expression ISO RGD:1313655 6480464 palbociclib results in decreased expression of TTK mRNA CTD PMID:22869556 paracetamol multiple interactions ISO RGD:1313656 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of TTK mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of TTK mRNA] CTD PMID:17585979 paracetamol decreases expression ISO RGD:1313655 6480464 Acetaminophen results in decreased expression of TTK mRNA CTD PMID:26690555 , PMID:29067470 paracetamol increases expression ISO RGD:1313655 6480464 Acetaminophen results in increased expression of TTK mRNA CTD PMID:22230336 perfluorononanoic acid decreases expression ISO RGD:1313655 6480464 perfluorononanoic acid results in decreased expression of TTK mRNA CTD PMID:32588087 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of TTK mRNA CTD PMID:31324951 phenobarbital multiple interactions ISO RGD:1313656 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of TTK mRNA CTD PMID:24535843 phenobarbital increases expression ISO RGD:1313656 6480464 Phenobarbital results in increased expression of TTK mRNA CTD PMID:23091169 PhIP increases expression ISO RGD:1313655 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of TTK mRNA CTD PMID:16120219 phytoestrogen increases expression ISO RGD:1313655 6480464 Phytoestrogens results in increased expression of TTK mRNA CTD PMID:18310284 piroxicam multiple interactions ISO RGD:1313655 6480464 Cisplatin promotes the reaction [Piroxicam results in decreased expression of TTK mRNA] CTD PMID:21858171 piroxicam decreases expression ISO RGD:1313655 6480464 Piroxicam results in decreased expression of TTK mRNA CTD PMID:21858171 potassium chromate decreases expression ISO RGD:1313655 6480464 potassium chromate(VI) results in decreased expression of TTK mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:1313655 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TTK mRNA CTD PMID:22079256 propanal decreases expression ISO RGD:1313655 6480464 propionaldehyde results in decreased expression of TTK mRNA CTD PMID:26079696 quercetin decreases expression ISO RGD:1313655 6480464 Quercetin results in decreased expression of TTK mRNA CTD PMID:21632981 resveratrol decreases expression ISO RGD:1313655 6480464 resveratrol results in decreased expression of TTK mRNA CTD PMID:15767336 resveratrol multiple interactions ISO RGD:1313655 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of TTK mRNA CTD PMID:19167446 resveratrol increases expression ISO RGD:1313655 6480464 resveratrol results in increased expression of TTK mRNA CTD PMID:19167446 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of TTK mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:1313655 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TTK mRNA CTD PMID:27188386 SCH 23390 multiple interactions EXP 6480464 [Methamphetamine co-treated with SCH 23390] results in decreased expression of TTK mRNA CTD PMID:19564919 senecionine increases expression EXP 6480464 senecionine results in increased expression of TTK mRNA CTD PMID:32419051 Senkirkine increases expression EXP 6480464 senkirkine results in increased expression of TTK mRNA CTD PMID:32419051 silicon dioxide increases expression ISO RGD:1313656 6480464 Silicon Dioxide results in increased expression of TTK mRNA CTD PMID:29341224 sirolimus multiple interactions ISO RGD:1313655 6480464 [fulvestrant co-treated with Sirolimus] results in decreased expression of TTK mRNA CTD PMID:19016759 sodium arsenite decreases expression ISO RGD:1313656 6480464 sodium arsenite results in decreased expression of TTK mRNA CTD PMID:17998272 sodium arsenite increases expression ISO RGD:1313655 6480464 sodium arsenite results in increased expression of TTK mRNA CTD PMID:29301061 sulforaphane increases expression ISO RGD:1313655 6480464 sulforafan results in increased expression of TTK mRNA CTD PMID:31838189 sunitinib decreases expression ISO RGD:1313655 6480464 Sunitinib results in decreased expression of TTK mRNA CTD PMID:31533062 testosterone multiple interactions ISO RGD:1313655 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of TTK mRNA CTD PMID:21592394 testosterone multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in decreased expression of TTK mRNA CTD PMID:26496021 testosterone decreases expression ISO RGD:1313655 6480464 Testosterone results in decreased expression of TTK mRNA CTD PMID:21592394 tetrachloromethane affects expression ISO RGD:1313656 6480464 Carbon Tetrachloride affects the expression of TTK mRNA CTD PMID:17484886 tetrachloromethane increases expression ISO RGD:1313656 6480464 Carbon Tetrachloride results in increased expression of TTK mRNA CTD PMID:29987408 , PMID:31919559 thalidomide multiple interactions ISO RGD:1313655 6480464 [Azacitidine co-treated with Thalidomide] affects the expression of TTK mRNA CTD PMID:18720364 thapsigargin increases expression ISO RGD:1313655 6480464 Thapsigargin results in increased expression of TTK mRNA CTD PMID:19442820 titanium dioxide affects expression ISO RGD:1313656 6480464 titanium dioxide affects the expression of TTK mRNA CTD PMID:17656681 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of TTK mRNA CTD PMID:30012374 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of TTK mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of TTK mRNA CTD PMID:25729387 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of TTK gene CTD PMID:27618143 trichostatin A decreases expression ISO RGD:1313655 6480464 trichostatin A results in decreased expression of TTK mRNA CTD PMID:26272509 trichostatin A multiple interactions ISO RGD:1313655 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TTK mRNA CTD PMID:27188386 trimellitic anhydride increases expression ISO RGD:1313656 6480464 trimellitic anhydride results in increased expression of TTK mRNA CTD PMID:19042947 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of TTK mRNA CTD PMID:30589522 Triptolide increases expression EXP 6480464 triptolide results in increased expression of TTK mRNA CTD PMID:23639586 troglitazone decreases expression ISO RGD:1313655 6480464 troglitazone results in decreased expression of TTK mRNA CTD PMID:19140230 valproic acid decreases expression ISO RGD:1313655 6480464 Valproic Acid results in decreased expression of TTK mRNA CTD PMID:23179753 more ... vincaleukoblastine affects response to substance ISO RGD:1313655 6480464 TTK protein affects the susceptibility to Vinblastine CTD PMID:16217747 zoledronic acid decreases expression ISO RGD:1313655 6480464 zoledronic acid results in decreased expression of TTK mRNA CTD PMID:24714768
Gene-Chemical Interaction Annotations
